FEED
Income statement / Annual
Last year (2025), ENvue Medical Inc.'s total revenue was $2.55 M,
a decrease of 0.20% from the previous year.
In 2025, ENvue Medical Inc.'s net income was -$18.19 M.
See ENvue Medical Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$2.55 M |
$2.56 M |
$2.28 M |
$752.00 K |
$1.70 M |
$623.00 K |
$530.00 K |
$318.00 K |
$239.00 K |
$229.00 K |
| Cost of Revenue |
$2.40 M
|
$1.05 M
|
$746.00 K
|
$585.00 K
|
$925.00 K
|
$409.00 K
|
$249.00 K
|
$158.00 K
|
$88.00 K
|
$88.00 K
|
| Gross Profit |
$153.00 K
|
$1.51 M
|
$1.54 M
|
$167.00 K
|
$770.00 K
|
$214.00 K
|
$281.00 K
|
$160.00 K
|
$151.00 K
|
$141.00 K
|
| Gross Profit Ratio |
0.06
|
0.59
|
0.67
|
0.22
|
0.45
|
0.34
|
0.53
|
0.5
|
0.63
|
0.62
|
| Research and Development Expenses |
$1.76 M
|
$909.00 K
|
$185.00 K
|
$283.00 K
|
$293.00 K
|
$171.00 K
|
$514.00 K
|
$614.00 K
|
$693.00 K
|
$584.00 K
|
| General & Administrative Expenses |
$7.63 M
|
$3.46 M
|
$3.92 M
|
$3.93 M
|
$5.06 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$2.49 M
|
$720.00 K
|
$864.00 K
|
$965.00 K
|
$1.10 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$10.13 M
|
$4.18 M
|
$4.79 M
|
$4.90 M
|
$6.16 M
|
$4.76 M
|
$4.92 M
|
$3.85 M
|
$2.55 M
|
$1.87 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$11.89 M
|
$5.09 M
|
$4.97 M
|
$5.18 M
|
$6.45 M
|
$4.93 M
|
$5.43 M
|
$4.46 M
|
$3.24 M
|
$2.46 M
|
| Cost And Expenses |
$14.29 M
|
$6.14 M
|
$5.72 M
|
$5.76 M
|
$7.38 M
|
$5.34 M
|
$5.68 M
|
$4.62 M
|
$3.33 M
|
$2.55 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$22.00 K
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$135.00 K
|
$246.00 K
|
$347.00 K
|
$0.00
|
$147.00 K
|
$62.00 K
|
$0.00
|
$1.29 M
|
$15.00 K
|
| Depreciation & Amortization |
$897.00 K
|
$1.00 K
|
$1.00 K
|
$1.00 K
|
$2.00 K
|
$2.00 K
|
$4.00 K
|
$6.00 K
|
$5.00 K
|
$7.00 K
|
| EBITDA |
-$10.84 M |
-$3.69 M |
-$3.44 M |
-$5.41 M |
-$14.25 M |
-$4.16 M |
-$5.75 M |
-$4.28 M |
-$3.64 M |
-$2.69 M |
| EBITDA Ratio |
-4.25
|
-1.44
|
-1.5
|
-7.2
|
-8.41
|
-6.68
|
-10.84
|
-13.44
|
-15.21
|
-11.76
|
| Operating Income Ratio |
-4.6
|
-1.4
|
-1.51
|
-6.66
|
-3.35
|
-7.57
|
-9.72
|
-13.53
|
-12.93
|
-10.11
|
| Total Other Income/Expenses Net |
-$6.76 M
|
-$104.00 K
|
-$246.00 K
|
-$401.00 K
|
-$8.57 M
|
$408.00 K
|
-$660.00 K
|
$22.00 K
|
-$1.84 M
|
-$398.00 K
|
| Income Before Tax |
-$18.49 M
|
-$3.69 M
|
-$3.68 M
|
-$5.41 M
|
-$14.25 M
|
-$4.31 M
|
-$5.81 M
|
-$4.28 M
|
-$4.93 M
|
-$2.71 M
|
| Income Before Tax Ratio |
-7.24
|
-1.44
|
-1.61
|
-7.2
|
-8.41
|
-6.92
|
-10.96
|
-13.46
|
-20.62
|
-11.85
|
| Income Tax Expense |
-$307.00 K
|
$19.00 K
|
$29.00 K
|
$35.00 K
|
$32.00 K
|
$15.00 K
|
-$17.00 K
|
-$127.00 K
|
$38.00 K
|
$117.00 K
|
| Net Income |
-$18.19 M
|
-$3.71 M
|
-$3.71 M
|
-$5.45 M
|
-$14.28 M
|
-$4.33 M
|
-$5.79 M
|
-$4.15 M
|
-$5.81 M
|
-$2.83 M
|
| Net Income Ratio |
-7.12
|
-1.45
|
-1.63
|
-7.24
|
-8.43
|
-6.94
|
-10.93
|
-13.06
|
-24.29
|
-12.36
|
| EPS |
-19.54 |
-137.3 |
-233.25 |
-422.14 |
-1248.68 |
-923.96 |
-1836.89 |
-1417.24 |
-2574 |
-1364 |
| EPS Diluted |
-19.54 |
-137.3 |
-233.25 |
-422.14 |
-1248.68 |
-923.96 |
-1836.89 |
-1417.24 |
-2574 |
-1364 |
| Weighted Average Shares Out |
$858.43 K
|
$26.98 K
|
$15.91 K
|
$12.91 K
|
$11.44 K
|
$4.68 K
|
$3.15 K
|
$2.93 K
|
$2.26 K
|
$2.08 K
|
| Weighted Average Shares Out Diluted |
$858.43 K
|
$26.98 K
|
$15.91 K
|
$12.91 K
|
$11.44 K
|
$4.68 K
|
$3.15 K
|
$2.93 K
|
$2.26 K
|
$2.08 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
